MEDCARA, L.L.C. – Trademark Portfolio

Entity Type: 16

MEDCARA, L.L.C. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include SEBDUO, OUTDOOR JOE'S, and DR. BOLDT'S BARRIER BALM. The owner is based in CONRAD, IA.

126 N. MAIN

CONRAD, IA 50621

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MEDCARA, L.L.C.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (9 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does MEDCARA, L.L.C. have?

MEDCARA, L.L.C. has 11 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned, 5 cancelled.

What trademark classes does MEDCARA, L.L.C. file in?

MEDCARA, L.L.C. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are MEDCARA, L.L.C.'s most well-known trademarks?

MEDCARA, L.L.C.'s registered trademark portfolio includes well-known marks such as SEBDUO, OUTDOOR JOE'S, and DR. BOLDT'S BARRIER BALM. These are among 4 currently registered trademarks in the portfolio.

What is MEDCARA, L.L.C.'s trademark registration success rate?

MEDCARA, L.L.C. has a 36% trademark registration rate, with 4 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.